
What election results say about health care costs; blood tests for Alzheimer’s reach primary care; heart attacks and late-onset epilepsy – Morning Medical Update
Key Takeaways
- Voter concerns about the economy and health care costs are increasingly intertwined, influencing election outcomes in Virginia and New Jersey.
- The FDA-approved Elecsys pTau181 blood test for Alzheimer's offers a less invasive, scalable diagnostic tool for primary care settings.
The top news stories in medicine today.
2025 election results from Virginia and New Jersey suggest that voters’ concerns about the economy and health care costs are increasingly intertwined. According to the 2025 Voter Poll, nearly half of Virginia voters and one-third of New Jersey voters cited the economy as their top issue, while about one in five prioritized health care — most of whom overwhelmingly supported Democratic candidates. In Virginia, the Democratic gubernatorial candidate won 81% of voters who named health care their main concern; in New Jersey, Democrat Mikie Sherrill captured 92% of that group. An analysis from
The first FDA-approved blood test for Alzheimer’s disease diagnosis, Roche’s Elecsys pTau181, could transform early detection and access to treatment. The test measures a phosphorylated form of the tau protein in blood plasma — an indicator of the amyloid and tau buildup characteristic of Alzheimer’s. Already authorized in Europe, Elecsys pTau181 is the first screening tool cleared for use in primary care, where it can help identify patients who should undergo more definitive testing such as PET imaging or cerebrospinal fluid analysis. With a 97.9% reliability in ruling out amyloid disease, the test offers a less invasive and more scalable alternative to current diagnostics. Its approval coincides with the rise of monoclonal antibody treatments that modestly slow symptom progression when started early. Experts caution, however, that the test’s positive results are less reliable and that it should not be used for self-screening or diagnosis without clinical evaluation. More from
Older adults who experience a heart attack could face an elevated risk of developing epilepsy later in life, according to a new study published in
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.



















